Literature DB >> 20572150

Measurement of perfusion and permeability from dynamic contrast-enhanced MRI in normal and pathological vertebral bone marrow.

Andreas Biffar1, Steven Sourbron, Gerwin Schmidt, Michael Ingrisch, Olaf Dietrich, Maximilian F Reiser, Andrea Baur-Melnyk.   

Abstract

Dynamic contrast-enhanced MRI data in vertebral bone marrow (vBM) are currently analyzed with descriptive indices. The purpose of this study was to develop and evaluate a quantitative approach, considering the tissue composition of vBM. Therefore, a measurement of the water fraction, f(wat), and the precontrast relaxation times, T(10 wat), T(10 fat), was added to the routine protocol. Signal analysis was generalized by allowing for an arbitrary fraction of fat. Plasma flow, plasma volume, extraction flow, and interstitial volume were determined from dynamic contrast-enhanced-MRI data. Simulations were used to determine the sensitivity to the precontrast values and to retrospectively verify the choice of the sequence parameters. Measurements were performed in healthy vertebral bodies (n = 30) and lesions of 15 patients with vertebral fractures. Extraction flow (milliliters per 100 mL/min) provided the strongest normal/abnormal separation: mean (standard deviation) was 0.3 (0.8) in healthy vBM and 6(4) in the fractures. Neglecting the fat component and the approximated signal analysis using relative signal enhancement produced significant differences. We conclude that correcting for the fat component in the signal and parametrization by tracer-kinetic analysis is necessary to avoid misinterpretation and/or systematic errors. The quantitative analysis is equally well suited as a descriptive parameter for the differentiation between normal and abnormal vertebral bone marrow. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20572150     DOI: 10.1002/mrm.22415

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  5 in total

1.  7T bone perfusion imaging of the knee using arterial spin labeling MRI.

Authors:  Xiufeng Li; Casey P Johnson; Jutta Ellermann
Journal:  Magn Reson Med       Date:  2019-12-24       Impact factor: 4.668

Review 2.  MRI for response assessment in metastatic bone disease.

Authors:  F E Lecouvet; A Larbi; V Pasoglou; P Omoumi; B Tombal; N Michoux; J Malghem; R Lhommel; B C Vande Berg
Journal:  Eur Radiol       Date:  2013-03-01       Impact factor: 5.315

Review 3.  Bone marrow MR perfusion imaging and potential for tumor evaluation.

Authors:  James F Griffith; R A van der Heijden
Journal:  Skeletal Radiol       Date:  2022-10-22       Impact factor: 2.128

4.  Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.

Authors:  Michele Anzidei; Alessandro Napoli; Beatrice Sacconi; Fabrizio Boni; Vincenzo Noce; Michele Di Martino; Luca Saba; Carlo Catalano
Journal:  Radiol Med       Date:  2016-08-27       Impact factor: 3.469

Review 5.  Quantitative MRI and spectroscopy of bone marrow.

Authors:  Dimitrios C Karampinos; Stefan Ruschke; Michael Dieckmeyer; Maximilian Diefenbach; Daniela Franz; Alexandra S Gersing; Roland Krug; Thomas Baum
Journal:  J Magn Reson Imaging       Date:  2017-06-01       Impact factor: 4.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.